I'm indifferent either way myself. It's just shocking the amount of ignorance.
166 karma · joined October 18, 2026
I'm indifferent either way myself. It's just shocking the amount of ignorance.
If you want deniability no one should be doing business with you.
If Claude goes down or stops existing when we go down, we're fucked.
Need more starfleet academy.
Now we know it's run by a dick too.
They sold fear. That was all.
Our products are both mature, entirely finished, fully deterministic and the last attempt at this using the same approach just burned all the money that was spent instead of generating any new revenue.
(not even joking)
When we had local, properly integrated AD no one had to log into anything other than their computer.
The whole SSO / SAML thing is a huge regression in usability.
If you have something security sensitive, it should be in a properly secured high side system not on the fucking public internet.
This is a valuable learning exercise for the SaaS consumers. I suspect it’ll be ignored as it’s convenient to point at the vendor and say it was them.
Trusting an SSO system, or anything with security sensitive data on the public internet presents an attack surface with untenable risk when your adversary is thousands of people with LLM tools.
It’s going to take a lot of this before people realise using someone else’s computer is a pretty fucking stupid idea.
I mean Entra and Okta got popped. That should have been the point companies looked at this risk and went nope.
This is just another one of those smells.
We already see that with software. It will be exactly the same with drug design.
My daughter is a leading biochem at one of the big pharma companies and that’s their principal worry about this. It’s really easy to create a lot of information these days which compromises the entire process.
About 50% of the test cases I've ever seen are pointless.
This precisely coincides with the web developers being allowed to wrap stuff into "apps" in Electron and the like.